High Tide Surpasses 200 Stores and Enters German Market in 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 23 2025
0mins
Should l Buy HITI?
Source: PRnewswire
- Store Expansion: High Tide successfully opened over 200 Canna Cabana locations in 2025, marking its evolution from a single store in 2018 to a globally recognized brand, thereby enhancing its competitive edge in the Canadian market.
- Membership Growth: The Canna Cabana membership surpassed 2 million, indicating a significant increase in customer loyalty and market penetration, further solidifying its market leadership.
- International Market Entry: High Tide officially entered the German medical cannabis market, becoming the first North American cannabis operator to establish a physical presence in Germany, signaling substantial growth potential in international markets.
- Financial Performance: Since the legalization of cannabis in Canada, High Tide has achieved over $2 billion in cumulative sales, demonstrating its robust operating model and positive cash flow, which is expected to support future expansion efforts.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HITI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HITI
Wall Street analysts forecast HITI stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.500
Low
7.50
Averages
7.50
High
7.50
Current: 2.500
Low
7.50
Averages
7.50
High
7.50
About HITI
High Tide Inc. is a retail-focused cannabis company. The Company’s segments include Bricks-and-mortar and E-commerce. Its Bricks-and-mortar segment includes the Company’s Canadian bricks-and-mortar locations. Its E-commerce segment includes the Company’s United States and international subsidiaries which sell cannabidiol (CBD) and consumption accessories. The Company operates 194 of its branded retail cannabis stores under the Canna Cabana brand, and two branded cannabis stores under the Meta Cannabis Supply Co brand, in addition to its Canadian warehouse operations which primarily service the retail locations in Canada. The Company operates its e-commerce platforms, including Smoke Cartel, Grasscity, Daily High Club, DankStop, NuLeaf Naturals and FABCBD, as well as USA sales on the international e-commerce platforms in the United States. In addition, the Company operates a warehouse which primarily services the e-commerce consumption accessories operations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
High Tide Joins National Compassionate Care Council as Founding Member
- Policy Transition Opportunity: High Tide Inc. announced its membership in the National Compassionate Care Council (NCCC) to help shape U.S. federal and state medical cannabis policies, indicating the company's proactive role in policy transformation aimed at improving patient access to cannabinoid therapies.
- Industry Leadership Position: The inclusion of NuLeaf Naturals, a leading U.S. CBD subsidiary, highlights High Tide's influence in the cannabis sector, particularly in advancing evidence-based policies and healthcare standards.
- Market Potential: With recent federal initiatives to reschedule cannabis and explore Medicare reimbursement, High Tide's U.S. CBD subsidiaries are poised to benefit, potentially expanding market share and enhancing business growth prospects.
- Brand Value Enhancement: By collaborating with the NCCC, High Tide can leverage its expertise in health brand development to strengthen brand image and increase consumer trust in its products, thereby driving sales growth.
See More
High Tide Joins National Compassionate Care Council as Founding Member
- Policy Transition Opportunity: High Tide Inc. announced its membership in the National Compassionate Care Council (NCCC), aiming to leverage its health brand expertise to influence U.S. federal and state medical cannabis policy, thereby improving patient access to cannabinoid therapies.
- Industry Collaboration: The NCCC brings together various organizations in the medical cannabis sector, and High Tide's participation not only enhances its industry influence but also supports efforts to advance evidence-based policies and improve product quality.
- Market Potential: With the shift in U.S. federal policy, particularly regarding cannabis rescheduling and Medicare reimbursement exploration, High Tide's U.S. subsidiaries are poised to benefit, potentially expanding their market share in the cannabis sector.
- Brand Strength: High Tide's subsidiaries, NuLeaf Naturals and FAB CBD, hold significant influence in the cannabinoid product space, showcasing a strong reputation with over 35,000 verified 5-star customer reviews, reflecting their competitive edge in the consumer market.
See More
High Tide Announces Board Changes and New Appointments
- Board Member Changes: High Tide announced the resignation of Nitin Kaushal and Andrea Elliott effective March 2, 2026, acknowledging their significant contributions during a period of substantial growth, particularly Kaushal's leadership in the Audit Committee and Elliott's role in the Compensation Committee, highlighting the company's commitment to board renewal.
- New Director Appointments: Kathleen Skerrett and Menashe Kestenbaum were appointed as new directors on March 2, 2026, with Skerrett's extensive expertise in securities law and corporate governance expected to aid the company's international expansion, while Kestenbaum's proven success in scaling public technology platforms will enhance governance complexity.
- Advisory Board Additions: David Wallach and Filip Ernest have been appointed to the Advisory Board, with Wallach's extensive experience in commercial real estate and Ernest's focus on digital transformation and AI expected to provide strategic guidance, supporting High Tide's diversified business development decisions.
- Grant of Stock Options and RSUs: The company granted 123,558 restricted stock units and 25,000 stock options to directors and advisors, with an exercise price of $3.43 per share, aimed at aligning management incentives with long-term company goals, thereby enhancing team cohesion and execution capabilities.
See More
High Tide Announces Board Changes and New Appointments
- Board Member Changes: High Tide announced the resignation of Nitin Kaushal and Andrea Elliott effective March 2, 2026, with both having significantly contributed to the company's growth since their tenures began in 2018 and 2021, reflecting ongoing governance optimization.
- New Director Appointments: Kathleen Skerrett and Menashe Kestenbaum were appointed as new directors on March 2, 2026, with Kathleen bringing extensive expertise in securities law and governance, while Menashe has proven experience in scaling public technology platforms, enhancing the company's capability to navigate complex market environments.
- Advisory Board Expansion: David Wallach and Filip Ernest were appointed to the Advisory Board, with David supervising over $500 million in real estate transactions and Filip focusing on AI and digital transformation, providing strategic guidance to support High Tide's future growth.
- Stock Options Granted: The company granted 123,558 restricted stock units and 25,000 stock options to directors and advisors, with an exercise price of $3.43 per share, aimed at aligning management incentives with long-term corporate goals and further driving international market expansion.
See More
High Tide Inc. Reports Q4 Earnings Results
- Earnings Highlights: High Tide Inc. reported a Q4 Non-GAAP EPS of C$0.02, indicating limited profitability but demonstrating the company's stability in the market.
- Revenue Growth: The company achieved Q4 revenue of C$164.03 million, representing an 18.6% year-over-year increase, which highlights significant sales growth in the competitive discount cannabis retail market.
- Market Position: As a discount cannabis retailer, High Tide Inc. maintains a relatively hidden competitive advantage despite industry challenges, attracting investor interest.
- Quant Rating: Seeking Alpha's Quant Rating on High Tide Inc. reflects cautious optimism regarding its future performance, indicating investor concern over its financial health.
See More
High Tide (HITI) to Announce Q4 Earnings on January 29
- Earnings Announcement Date: High Tide (HITI) is set to release its Q4 earnings on January 29 after market close, with a consensus EPS estimate of $0.01, reflecting a significant year-over-year increase of 116.7%, indicating improved profitability.
- Revenue Expectations Decline: Despite the optimistic EPS forecast, the revenue estimate stands at $116.1 million, representing a 16.1% year-over-year decline, suggesting increased market competition and sales pressure may impact overall performance.
- Historical Performance Review: Over the past two years, HITI has only beaten EPS estimates 13% of the time, yet has exceeded revenue estimates 100% of the time, indicating strong revenue management despite fluctuations in profitability.
- Market Attention: As a discount cannabis retailer, High Tide's hidden position in the market, despite facing challenges, may present unique opportunities for investors, warranting close attention to its future financial performance and market strategies.
See More
High Tide Joins National Compassionate Care Council as Founding Member
- Policy Transition Opportunity: High Tide Inc. announced its membership in the National Compassionate Care Council (NCCC) to help shape U.S. federal and state medical cannabis policies, indicating the company's proactive role in policy transformation aimed at improving patient access to cannabinoid therapies.
- Industry Leadership Position: The inclusion of NuLeaf Naturals, a leading U.S. CBD subsidiary, highlights High Tide's influence in the cannabis sector, particularly in advancing evidence-based policies and healthcare standards.
- Market Potential: With recent federal initiatives to reschedule cannabis and explore Medicare reimbursement, High Tide's U.S. CBD subsidiaries are poised to benefit, potentially expanding market share and enhancing business growth prospects.
- Brand Value Enhancement: By collaborating with the NCCC, High Tide can leverage its expertise in health brand development to strengthen brand image and increase consumer trust in its products, thereby driving sales growth.
See More
High Tide Joins National Compassionate Care Council as Founding Member
- Policy Transition Opportunity: High Tide Inc. announced its membership in the National Compassionate Care Council (NCCC), aiming to leverage its health brand expertise to influence U.S. federal and state medical cannabis policy, thereby improving patient access to cannabinoid therapies.
- Industry Collaboration: The NCCC brings together various organizations in the medical cannabis sector, and High Tide's participation not only enhances its industry influence but also supports efforts to advance evidence-based policies and improve product quality.
- Market Potential: With the shift in U.S. federal policy, particularly regarding cannabis rescheduling and Medicare reimbursement exploration, High Tide's U.S. subsidiaries are poised to benefit, potentially expanding their market share in the cannabis sector.
- Brand Strength: High Tide's subsidiaries, NuLeaf Naturals and FAB CBD, hold significant influence in the cannabinoid product space, showcasing a strong reputation with over 35,000 verified 5-star customer reviews, reflecting their competitive edge in the consumer market.
See More
High Tide Announces Board Changes and New Appointments
- Board Member Changes: High Tide announced the resignation of Nitin Kaushal and Andrea Elliott effective March 2, 2026, acknowledging their significant contributions during a period of substantial growth, particularly Kaushal's leadership in the Audit Committee and Elliott's role in the Compensation Committee, highlighting the company's commitment to board renewal.
- New Director Appointments: Kathleen Skerrett and Menashe Kestenbaum were appointed as new directors on March 2, 2026, with Skerrett's extensive expertise in securities law and corporate governance expected to aid the company's international expansion, while Kestenbaum's proven success in scaling public technology platforms will enhance governance complexity.
- Advisory Board Additions: David Wallach and Filip Ernest have been appointed to the Advisory Board, with Wallach's extensive experience in commercial real estate and Ernest's focus on digital transformation and AI expected to provide strategic guidance, supporting High Tide's diversified business development decisions.
- Grant of Stock Options and RSUs: The company granted 123,558 restricted stock units and 25,000 stock options to directors and advisors, with an exercise price of $3.43 per share, aimed at aligning management incentives with long-term company goals, thereby enhancing team cohesion and execution capabilities.
See More
High Tide Announces Board Changes and New Appointments
- Board Member Changes: High Tide announced the resignation of Nitin Kaushal and Andrea Elliott effective March 2, 2026, with both having significantly contributed to the company's growth since their tenures began in 2018 and 2021, reflecting ongoing governance optimization.
- New Director Appointments: Kathleen Skerrett and Menashe Kestenbaum were appointed as new directors on March 2, 2026, with Kathleen bringing extensive expertise in securities law and governance, while Menashe has proven experience in scaling public technology platforms, enhancing the company's capability to navigate complex market environments.
- Advisory Board Expansion: David Wallach and Filip Ernest were appointed to the Advisory Board, with David supervising over $500 million in real estate transactions and Filip focusing on AI and digital transformation, providing strategic guidance to support High Tide's future growth.
- Stock Options Granted: The company granted 123,558 restricted stock units and 25,000 stock options to directors and advisors, with an exercise price of $3.43 per share, aimed at aligning management incentives with long-term corporate goals and further driving international market expansion.
See More
High Tide Inc. Reports Q4 Earnings Results
- Earnings Highlights: High Tide Inc. reported a Q4 Non-GAAP EPS of C$0.02, indicating limited profitability but demonstrating the company's stability in the market.
- Revenue Growth: The company achieved Q4 revenue of C$164.03 million, representing an 18.6% year-over-year increase, which highlights significant sales growth in the competitive discount cannabis retail market.
- Market Position: As a discount cannabis retailer, High Tide Inc. maintains a relatively hidden competitive advantage despite industry challenges, attracting investor interest.
- Quant Rating: Seeking Alpha's Quant Rating on High Tide Inc. reflects cautious optimism regarding its future performance, indicating investor concern over its financial health.
See More
High Tide (HITI) to Announce Q4 Earnings on January 29
- Earnings Announcement Date: High Tide (HITI) is set to release its Q4 earnings on January 29 after market close, with a consensus EPS estimate of $0.01, reflecting a significant year-over-year increase of 116.7%, indicating improved profitability.
- Revenue Expectations Decline: Despite the optimistic EPS forecast, the revenue estimate stands at $116.1 million, representing a 16.1% year-over-year decline, suggesting increased market competition and sales pressure may impact overall performance.
- Historical Performance Review: Over the past two years, HITI has only beaten EPS estimates 13% of the time, yet has exceeded revenue estimates 100% of the time, indicating strong revenue management despite fluctuations in profitability.
- Market Attention: As a discount cannabis retailer, High Tide's hidden position in the market, despite facing challenges, may present unique opportunities for investors, warranting close attention to its future financial performance and market strategies.
See More
